BLOG / 🇺🇸 United States / earnings results · · daily

US Earnings Financial Results SEC Filings — November 05, 2026

Financial Results & Earnings

By Gunpowder Editorial ·

50 high priority 50 total filings analysed

Executive Summary

The Q3 2026 earnings season reveals a market characterized by robust top-line growth but widening dispersion in profitability and cash flow quality.

Revenue growth is strong across technology, consumer, and industrial sectors—Cloudflare +39%, Oscar Health +72%, Pattern Group +38.5%, and WaterBridge +94.9%—yet margin pressures and one-time charges are pervasive, with 60% of filers reporting mixed sentiment due to cost inflation, restructuring, or impairments. Capital allocation is aggressive: Tapestry repurchased $603M in stock, Snap $601M, and American Homes 4 Rent $313M, while dividend increases (First Bancorp, Arhaus) and debt reductions (Watts Water, Regis) signal confidence in balance sheet strength. However, cash flow quality is deteriorating at several companies—Duke Energy's operating cash flow fell 9% while capex surged 27%, and Packaging Corp's working capital consumed $292.5M—raising questions about the sustainability of growth. Insider activity is notably absent from the enriched data, limiting conviction signals, but forward-looking guidance and scheduled events suggest upcoming catalysts in biotech (Dyne, Amylyx) and energy (Chord, Genesis). Overall, the filings point to a late-cycle environment where revenue growth is decelerating from peak levels, margin expansion is harder to achieve, and investors must scrutinize cash conversion and balance sheet flexibility.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 10-Q

Tracking the trend? Catch up on the prior US Earnings Financial Results SEC Filings digest from November 04, 2026.

Investment Signals (12)

  • Cloudflare (NET) (BULLISH)
    ▲

    Revenue grew 39.2% YoY to $782.5M, but operating loss widened to $(67.9)M due to a $161.7M restructuring charge; excluding this, adjusted profitability may be stronger than reported, and the company refinanced $4.44B in convertible notes, extending maturities

  • Oscar Health (OSCR) (BULLISH)
    ▲

    Revenue surged 72% YoY to $5.14B, swinging to net income of $167.3M from a loss; medical costs rose 64% (below premium growth of 72%), and accumulated deficit narrowed by $1.2B, indicating improving fundamentals

  • Tapestry (TPR) (BULLISH)
    ▲

    Net sales rose 11.1% YoY with EPS up 37.5% to $1.76; gross margin expanded 230 bps to 78.6%, and operating cash flow more than doubled to $197M, funding $603M in buybacks

  • Watts Water (WTS) (BULLISH)
    ▲

    Net sales grew 19.0% YoY to $728.0M and net income jumped 76.9% to $145.4M; long-term debt was reduced by 51% to $98.2M, strengthening the balance sheet

  • Yum China (YUMC) (BULLISH)
    ▲

    Revenue rose 8.5% YoY to $3.48B with net income up 10.3%; diluted EPS grew 19.7% to $0.91 due to a 7% share count reduction, and operating margin expanded 50 bps to 13.0%

  • GigaCloud (GCT) (BULLISH)
    ▲

    Revenue grew 27.3% YoY to $423.6M and net income rose 36.1% to $50.6M; nine-month operating cash flow was strong, and the company repurchased $60M in shares, signaling confidence

  • Snap (SNAP) (BULLISH)
    ▲

    Revenue grew 14.3% YoY to $1.72B, swinging to net income of $56.5M from a loss; other revenue (subscriptions) surged 84.4% and now represents 20% of total, diversifying away from advertising

  • Evergy (EVRG) (BULLISH)
    ▲

    Q3 revenue rose 15.8% YoY to $2.10B and net income jumped 29.0% to $612.9M; YTD diluted EPS reached $4.14 vs $3.31, and the company raised $322.2M in equity and $2.31B in debt to fund capital projects

  • Chord Energy (CHRD) (BULLISH)
    ▲

    Operating cash flow for 9M 2026 rose 47% to $2.41B, and Q3 operating income increased to $505.0M from $170.8M; despite a $246M derivative loss, underlying operations are strong

  • Duke Energy (DUK) (BULLISH)
    ▲

    Q3 EPS rose 9.9% to $1.99 and YTD EPS increased 11% to $5.34; the company benefited from a $368M gain on the sale of Piedmont's Tennessee business, and continues to invest heavily in infrastructure

  • BeOne Medicines (BGNE) (BULLISH)
    ▲

    Net income surged to $384.7M in Q3 from $124.8M, and nine-month net income reached $849.1M vs $220.4M; cash rose to $5.78B, and R&D expense fell, boosting profitability

  • Pattern Group (PTRN) (BULLISH)
    ▲

    Revenue grew 38.5% YoY to $885.8M, swinging to net income of $32.1M from a loss; the Amazon channel grew 34.5% and SaaS/logistics grew 136%, though inventory build and payables supported cash flow

Risk Flags (10)

  • Medallion Financial (MFIN) [HIGH RISK]
    ▼

    Net income plummeted 69% YoY to $2.4M as the provision for credit losses jumped 65.8% to $30.8M; total other income fell 56.8% due to a loss on equity investments, and stockholders' equity declined

  • Inseego (INSG) [HIGH RISK]
    ▼

    Revenue fell 27.5% YoY to $33.3M, gross margin compressed to 33% from 42%, and the company swung to a net loss of $8.1M from a profit; cash fell to $6.6M from $24.9M, and stockholders' deficit deepened to $36.6M

  • Traeger (COOK) [HIGH RISK]
    ▼

    Revenue plunged 40.4% YoY to $74.7M, and gross margin contracted to 33.5% from 38.7%; while the net loss narrowed due to a prior-year impairment, the top-line collapse signals severe demand weakness

  • CION Investment (CION) [HIGH RISK]
    ▼

    Net investment income dropped 68% YoY to $12.3M, and net asset value per share fell to $13.20 from $13.76; total investment income fell 38.6%, and the portfolio shrank 17.2%

  • Eve Holding (EVEX) [HIGH RISK]
    ▼

    Net loss widened to $58.1M in Q3, and shareholders' equity turned negative at $(34.5)M; long-term debt rose to $313.6M, and cash used in operations widened to $166.9M

  • Perma-Fix (PESI)↓ [HIGH RISK]
    ▼

    Gross margin collapsed to ~3% from ~15%, and the nine-month net loss widened to $17.1M from $8.1M; revenue declined 8.7%, and cost of goods sold rose sharply

  • NewLake Capital (NLCP) [HIGH RISK]
    ▼

    Net income fell 37% YoY to $4.2M as depreciation and amortization jumped 79%; revenue declined 4.5%, and the company repaid its revolver, leaving cash at $17.9M

  • Insight Enterprises (NSIT) [HIGH RISK]
    ▼

    Q3 net earnings fell 56.5% YoY to $22.2M despite 21.8% sales growth, as SG&A rose 28.8% and severance costs quadrupled; operating cash flow was weak at $148.5M due to working capital build

  • Kimball Electronics (KE) [HIGH RISK]
    ▼

    Net income fell 73.8% YoY to $2.6M as the effective tax rate spiked to ~66% and interest expense rose 49.6%; operating cash flow swung to a $19.3M outflow on inventory build

  • Novavax (NVAX) [HIGH RISK]
    ▼

    Nine-month revenue fell 72.9% YoY to $264.5M, and the company swung to a net loss of $94.3M from a profit; stockholders' deficit widened to $216.9M, and cash declined to $622.4M

Opportunities (10)

  • Dyne Therapeutics (DYN) (OPPORTUNITY)
    ◆

    Cash of $1.13B provides a long runway, and the company raised $404.9M in Q3; R&D expense rose 66% YoY, indicating pipeline advancement, with potential catalysts from clinical data readouts

  • Amylyx Pharmaceuticals (AMLX) (OPPORTUNITY)
    ◆

    Cash increased to $768.1M after a $544.6M financing, and the net loss per share improved to $(1.15) from $(1.25) YTD; the company has ample capital to fund late-stage trials

  • Centrus Energy (LEU) (OPPORTUNITY)
    ◆

    Cash rose to $2.24B from $1.96B, and the company raised $493.8M from warrant exercises; despite a Q3 operating loss, the domestic enrichment expansion capex of $226.4M positions it for long-term growth

  • Genesis Energy (GEL) (OPPORTUNITY)
    ◆

    Nine-month net income swung to $52.1M from a $460.3M loss, and the company issued $750M in senior notes to refinance debt; the marine segment showed growth, and the preferred unit redemption simplifies the capital structure

  • Arhaus (ARHS) (OPPORTUNITY)
    ◆

    Client deposits rose 37.7% to $325.0M, supporting operating cash flow; while net income fell 36% in Q3 due to SG&A growth, the deposit build signals strong future revenue recognition

  • Citizens Financial Services (CZFS) (OPPORTUNITY)
    ◆

    Net income rose 19.2% YoY to $11.9M, and the Q3 provision for credit losses dropped to zero from $0.5M; the bank's net interest income grew 8.4%, and total assets expanded 11.4%

  • First Bancorp (FNLC) (OPPORTUNITY)
    ◆

    Net income rose 17.5% YoY to $10.7M, and the dividend was increased to $0.38 from $0.37; the payout ratio improved to 39.6% from 45.2%, and deposit growth was strong

  • Unity Software (U) (OPPORTUNITY)
    ◆

    Q3 revenue grew 32.2% YoY to $622.1M, swinging to net income of $121.6M from a loss; nine-month operating cash flow rose 66.1% to $500.9M, and the company reduced intangible assets through impairments, cleaning up the balance sheet

  • Chime Financial (CHYM) (OPPORTUNITY)
    ◆

    Revenue grew 32.1% YoY to $718.0M, swinging to net income of $43.7M from a loss; stock-based compensation plummeted to $204.3M from $1.00B, and member support costs fell 20.4%, driving operating leverage

  • Core Natural Resources (CNR) (OPPORTUNITY)
    ◆

    Nine-month net income swung to $156.5M from a loss, and Q3 operating income turned positive; G&A costs were cut 26.4%, and cash from operations rose, though Q3 net income fell due to tax benefits

Sector Themes (6)

  • Margin Compression Amid Revenue Growth
    ◆

    Across 50 filings, 28 companies reported revenue growth exceeding 10% YoY, yet 18 of those experienced margin compression or net income declines. Examples: Insight Enterprises (sales +21.8%, net income -56.5%), Kimball Electronics (sales +6.9%, net income -73.8%), and Packaging Corp (sales +12.5%, net income +15.6% but nine-month net income -7.0%). This suggests cost inflation and operating leverage are deteriorating, pressuring profitability despite top-line strength.

  • Aggressive Capital Returns
    ◆

    Share repurchases were prominent: Tapestry ($603M), Snap ($601M), American Homes 4 Rent ($313M), Insight Enterprises ($225M), and GigaCloud ($60M). Dividend increases were modest (First Bancorp +2.7%, Arhaus initiated), while debt reduction was significant at Watts Water (-51% LT debt) and Regis (-$8.5M). Companies are prioritizing buybacks over dividends, signaling confidence in undervaluation but potentially limiting financial flexibility.

  • Cash Flow Quality Deterioration
    ◆

    Operating cash flow lagged net income at several companies due to working capital builds. Packaging Corp consumed $292.5M from receivables/inventories, Duke Energy's operating cash flow fell 9% while capex surged 27%, and Insight Enterprises' operating cash flow was flat despite revenue growth. This raises red flags about earnings quality and the sustainability of growth.

  • Healthcare and Biotech Funding Surge
    ◆

    Biotech firms raised significant capital: Dyne ($404.9M), Amylyx ($544.6M), and Korro Bio ($80.3M private placement). Cash balances are strong, but R&D expenses are rising (Dyne +66%, Amylyx +38%), indicating a race to advance pipelines. Oscar Health's profitability swing (+$167M net income) shows the potential for scale in insurtech.

  • Energy Transition and Infrastructure Spending
    ◆

    Utilities and energy companies are investing heavily: Duke Energy capex +27.2% to $12.57B, Evergy raised $2.31B in debt, and Centrus Energy capex jumped to $226.4M for enrichment expansion. This trend supports industrial and materials demand but pressures near-term cash flows and increases leverage.

  • Consumer Discretionary Divergence
    ◆

    While Tapestry and Ralph Lauren posted strong growth (11.1% and 9.1% respectively), others like Traeger (-40.4%) and Regis (-7.8%) struggled. The divergence highlights a bifurcated consumer: premium/luxury brands are thriving, while discretionary and salon services are under pressure from inflation and changing spending patterns.

Watch List (8)

  • Dyne Therapeutics (DYN)
    👁

    Watch for clinical trial data readouts in 2027; cash of $1.13B provides runway, but R&D spending is accelerating. Next earnings call likely February 2027.

  • Cloudflare (NET)
    👁

    Monitor the impact of the $161.7M restructuring charge and the $4.44B convertible notes refinancing; operating margin improvement is key. Next earnings call February 2027.

  • Oscar Health (OSCR)
    👁

    Watch for medical cost trends and membership growth; the company swung to profitability, but payables to CMS surged to $4.63B, which could reverse. Next earnings call February 2027.

  • Duke Energy (DUK)
    👁

    Monitor the funding gap as capex outpaces operating cash flow; the company raised $9.55B in new debt and $2.84B in NCI contributions. Regulatory approvals for rate increases are critical. Next earnings call February 2027.

  • Centrus Energy (LEU)
    👁

    Watch for progress on the domestic enrichment expansion and potential government contracts; cash of $2.24B is strong, but operating losses persist. Next earnings call February 2027.

  • Tapestry (TPR)
    👁

    Monitor inventory levels (+27.7% YoY) and consumer demand; the company repurchased $603M in stock, reducing equity to $344M. Next earnings call February 2027.

  • Medallion Financial (MFIN)
    👁

    Watch credit quality trends; the provision for credit losses jumped 65.8%, and non-performing loans may rise further. Next earnings call February 2027.

  • Eve Holding (EVEX)
    👁

    Monitor liquidity as shareholders' equity turned negative; the company may need to raise additional capital. Next earnings call February 2027.

Filing Analyses (50)
Chord Energy Corp 10-Q mixed materiality 8/10

05-11-2026

Chord Energy Corp (CHRD) reported Q3 2026 total revenues of $1,705.9M, up 30.0% YoY from $1,312.1M, and net income of $181.6M versus $130.1M in Q3 2025 (+39.6%). Nine-month net income reached $815.4M versus a net loss of $(40.0)M in the prior-year period, though Q3 results were weighed down by a $(246.0)M derivative loss, and Q3 derivative losses also drove other expense to $(259.4)M from $(0.5)M a year earlier. Net debt-related and operating cost pressures persisted, with production taxes rising 45.7% YoY in Q3 and interest expense up 42.9%.

  • · Q3 2026 operating income rose to $505.0M from $170.8M, but a $(246.0)M derivative loss in Q3 2026 (versus a $20.7M gain in Q3 2025) cut pre-tax income to $245.6M from $170.3M.
  • · Operating cash flow for 9M 2026 was $2,405.0M, up 47.0% from $1,635.7M, while capital expenditures rose modestly to $1,097.3M from $1,044.8M.
  • · Stockholders' equity increased to $8,266.6M from $8,080.0M, supported by retained earnings growth to $2,639.0M, while treasury stock rose to $1,731.3M from $1,304.1M.
  • · Total liabilities rose to $5,704.7M from $4,994.3M, driven by a $163.5M current derivative liability and higher revenues and production taxes payable.
  • · Accounts receivable rose 29.7% to $1,448.2M from $1,116.7M, absorbing $360.3M of operating cash in 9M 2026.
  • · Derivative instruments moved from a $77.3M current asset at December 31, 2025 to a $163.5M current liability at September 30, 2026.
  • · Assets held for sale totaled $444.4M in current assets and $52.9M in liabilities at September 30, 2026, with a $55.0M deposit received tied to the disposition.
  • · Net cash used in financing activities was $(644.3)M in 9M 2026, versus a $7.0M inflow in 9M 2025, as the company repaid no senior notes and repurchased $418.7M of common stock.
  • · Impairment and exploration expense fell 98.7% to $7.3M for 9M 2026 from $546.0M in 9M 2025, when a large impairment charge was recorded.
  • · Income tax expense for 9M 2026 was $211.9M, up 26.4% from $167.6M, while cash paid for income taxes rose to $119.2M from $73.1M.
Dyne Therapeutics, Inc. 10-Q mixed materiality 8/10

05-11-2026

Dyne Therapeutics reported a Q3 2026 net loss of $193.6 million ($1.06 per share), up from a $108.0 million loss ($0.76 per share) in Q3 2025, a 79% increase. Operating expenses rose to $197.1 million from $113.9 million, driven by R&D of $161.7 million (up 66%) and G&A of $35.3 million (up 112%). Cash, cash equivalents and marketable securities totaled roughly $1.13 billion at September 30, 2026, supported by a $404.9 million public offering in Q3, though net cash used in operations for the nine months reached $452.7 million.

  • · Q3 2026 interest expense rose about 105% to $5.9M from $2.9M, reflecting higher long-term debt ($200.0M vs. $148.9M at year-end 2025).
  • · Property and equipment, net fell to $7.1M from $24.0M at December 31, 2025, a decline of about 70%.
  • · Accumulated other comprehensive position swung from a $0.5M gain to a $1.0M loss, reflecting unrealized losses on marketable securities.
  • · Accumulated deficit reached $1.89B at September 30, 2026, up from $1.40B at year-end 2025.
  • · Cash, cash equivalents and marketable securities combined (about $1.13B) were broadly stable versus year-end 2025 (about $1.11B), with the Q3 equity raise offsetting cash burn.
  • · Q1 2026 and Q2 2026 quarterly net losses were $120.9M and $178.6M, showing a steadily accelerating loss trajectory through the year.
NOVAVAX INC 10-Q mixed materiality 8/10

05-11-2026

Novavax reported Q3 2026 total revenue of $68.3M, down 3.0% YoY from $70.4M, and a net loss of $31.4M versus a $202.4M loss in Q3 2025 (which included a $97.0M asset impairment and $28.7M debt extinguishment loss). For the nine months, revenue fell 72.9% YoY to $264.5M from $976.3M, and net loss was $94.3M versus net income of $422.8M a year earlier. Cash, cash equivalents, and marketable securities totaled $622.4M at September 30, 2026, down from $735.1M at year-end 2025, and stockholders' deficit widened to $216.9M.

  • · Product sales rose 91% YoY in Q3 2026 to $25.7M, while licensing, royalties, and other revenue fell 25% to $42.6M, indicating a shift in revenue mix
  • · Nine-month net cash used in operations was $199.5M, roughly flat versus $205.2M in the prior-year period
  • · Deferred revenue declined to $330.0M non-current and $102.2M current, down from $358.9M and $140.1M at year-end 2025
  • · Stockholders' deficit deepened to $216.9M from $127.8M at December 31, 2025, with accumulated other comprehensive loss increasing to $10.8M
  • · Long-term debt rose to $292.1M from $244.2M, supported by $46.4M in net credit facility proceeds in 2026
  • · Inventory increased 60% to $18.5M from $11.5M at year-end 2025
Holley Inc. 10-Q mixed materiality 6/10

05-11-2026

Holley Inc. reported Q3 FY2026 (thirteen weeks ended September 27, 2026) net sales of $141.6M, up 2.3% from $138.4M in the prior-year quarter, with net income of $7.8M versus a net loss of $0.8M a year earlier. Results were mixed: nine-month net sales rose 0.6% to $460.9M and net income slipped 1.7% to $12.7M, while operating income for the nine months fell 36.5% to $39.8M, driven by a $28.6M loss on sale of assets.

  • · Gross margin expanded to 44.0% in Q3 FY2026 from 43.2% a year earlier, but nine-month gross profit was essentially flat at $193.5M.
  • · Nine-month SG&A rose 5.4% to $108.7M, and restructuring costs more than doubled to $4.5M from $2.2M.
  • · Interest expense fell 31.3% for the nine months to $27.7M from $40.3M, supporting bottom-line results despite lower operating income.
  • · Nine-month operating cash flow rose 45.6% to $58.3M from $40.1M, while capex increased 50.0% to $14.9M.
  • · Inventories fell to $181.6M from $205.7M at year-end 2025, a 11.7% reduction that contributed to cash generation.
  • · Accounts payable outflow of $15.5M and principal debt repayments of $28.3M (up from $18.6M) were notable cash uses.
  • · Nine-month foreign currency translation turned negative at $(2.6)M versus a $1.3M gain a year earlier.
WATTS WATER TECHNOLOGIES INC 10-Q mixed materiality 8/10

05-11-2026

Watts Water Technologies reported strong third-quarter 2026 results, with net sales up 19.0% YoY to $728.0M and net income up 76.9% to $145.4M (diluted EPS $4.34 vs. $2.45). Nine-month net sales rose 19.6% to $2,168.4M and net income rose 41.3% to $363.3M. Results were not uniformly positive: SG&A grew faster than sales at 13.5% for the quarter, operating cash flow for the nine months was up only modestly (+12.8%), free cash flow was constrained by higher capex, and accumulated other comprehensive loss widened.

  • · Long-term debt was reduced by $100.0M (roughly 51%) during the nine months, from $197.7M to $98.2M.
  • · Cumulative accumulated goodwill impairment reached $167.1M, with Europe ($129.7M) and Americas ($24.5M) carrying most of it; goodwill net fell to $859.1M, with a $3.6M decline in the nine months (including $3.7M of Europe impairment-related reduction).
  • · Accounts receivable rose 35.8% to $399.3M since year-end, outpacing sales growth and consuming $109.0M of operating cash in the nine months.
  • · Capital expenditures rose 55.9% to $48.8M for the nine months, reducing free cash flow to roughly $230.1M versus $216.0M in the prior year (+6.5%), a smaller gain than net income growth.
  • · Accumulated other comprehensive loss widened to $(138.0)M from $(127.5)M, reversing much of the prior-year translation gain ($48.1M in 9M 2025 vs. $(9.9)M in 9M 2026).
  • · Dividends declared per share rose to $0.63 in Q3 (from $0.52), and nine-month dividends paid were $60.0M versus $49.4M.
  • · Share count was essentially flat at roughly 33.5M weighted average shares, so EPS growth is driven by earnings rather than buybacks ($11.8M repurchased for the nine months, unchanged YoY).
  • · Restructuring charges fell sharply to $6.1M for nine months from $22.6M, a 73% decline.
RALPH LAUREN CORP 10-Q mixed materiality 8/10

05-11-2026

Ralph Lauren reported Q2 FY2027 (quarter ended September 26, 2026) net revenues of $2,193.3 million, up 9.1% YoY from $2,010.7 million, with net income rising 42.9% to $296.6 million and diluted EPS up to $4.87 from $3.32. Growth was led by Retail (+11.8%) and Wholesale (+5.4%), while Licensing declined 9.0% and Asia Wholesale-adjacent momentum was mixed; SG&A grew faster than revenue (+10.9%), and restructuring charges rose 69.4% to $63.2 million. Six-month net revenues rose 11.3% to $4,153.1 million and operating cash flow improved sharply to $618.2 million from $229.3 million, though inventories grew 13.5% and cash fell 28.3% to $1,426.1 million as buybacks of $626.6 million exceeded free cash generation.

  • · Gross margin expanded to 74.2% in Q2 FY2027 from 68.0% in Q2 FY2026, driven by lower cost of goods sold ($565.4M vs $644.3M), partially offset by higher SG&A.
  • · Effective tax rate rose to 19.7% in Q2 FY2027 from 14.5% in Q2 FY2026 ($72.6M vs $35.3M tax provision), a headwind to net income growth.
  • · Asia revenues grew 28.2% YoY to $571.3M in Q2 FY2027, while North America grew 6.4% and Europe grew 1.1%.
  • · Six-month inventories rose $134.2M in operating cash flow, versus a $281.6M build in the prior year period, a relative improvement.
  • · Six-month share repurchases of $630.0M (equity statement) exceeded dividends of $118.7M declared, with treasury stock increasing to $8,991.9M.
  • · Total equity declined from $2,841.4M at March 28, 2026 to $2,729.8M at September 26, 2026 because buybacks outpaced retained earnings growth.
TELEFLEX INC 10-Q mixed materiality 8/10

05-11-2026

Teleflex reported Q3 2026 net revenues of $567.8M, up 0.2% YoY from $566.9M, with income from continuing operations of $54.3M versus a $58.4M loss a year earlier. Net income swung to $927.4M (vs. a $408.9M loss) driven almost entirely by $873.1M of income from discontinued operations, while nine-month net revenues rose 18.4% to $1,686.4M. Growth was flat at the top line for the quarter: Vascular grew 4.7% and Surgical 4.3%, but Interventional declined 2.6% YoY, and Rest of World revenue fell 0.8% (ex-Other), with North America up 0.9%.

  • · Interventional segment revenue declined 2.6% YoY in Q3 2026 and was the only segment to shrink in North America-plus-RoW aggregate terms
  • · Q3 2026 SG&A rose 6.4% YoY to $220.7M and R&D fell 2.9% to $43.0M
  • · Restructuring and impairment items were a $0.3M credit in Q3 2026 versus a $102.8M charge in Q3 2025, a major driver of the operating improvement
  • · Nine-month 2026 share repurchases totaled $555.0M in cash, while long-term borrowings fell from $2,541.4M to $1,531.5M after $3,368.1M of debt reductions
  • · Income taxes payable rose sharply to $194.6M from $18.8M at year-end 2025, a liquidity item worth monitoring
  • · Q3 2026 Other revenue of $9.0M in the prior year did not recur
Leapfrog Acquisition Corp 10-Q mixed materiality 5/10

05-11-2026

Leapfrog Acquisition Corp (LFAC), a blank-check SPAC, reported net income of $1,188,406 for the three months ended September 30, 2026 and $3,388,244 for the nine months, driven almost entirely by $1,303,187 and $3,813,404 of interest earned on its Trust Account. Operating costs rose sharply, with G&A expenses of $114,781 in the quarter (up from $54,875 a year earlier) and $425,160 year-to-date (versus $60,889 in the prior inception period), while the company carries a $4,101,351 shareholders' deficit and a $5,031,250 deferred underwriting fee. Trust Account value per redeemable share rose to $10.29 from $10.02 at year-end 2025.

  • · Operating cash fell 37.1% from $1,395,995 to $877,781 year-to-date, with $518,214 used in operations, a meaningful drain on liquidity for a company with no operating business.
  • · Accounts payable and accrued expenses declined from $217,300 to $23,426, while amounts due to the Sponsor rose from $7,500 to $56,007.
  • · Net income per share was $0.06 for the quarter and $0.17 year-to-date for both redeemable and non-redeemable shares, entirely attributable to trust interest income rather than operations.
  • · The shareholders' deficit widened by $425,160 over nine months, reflecting remeasurement of redeemable shares to trust value and reducing the equity cushion.
First Bancorp, Inc /ME/ 10-Q mixed materiality 6/10

05-11-2026

First Bancorp, Inc /ME/ (FNLC) reported Q3 2026 net income of $10.7M ($0.96 basic EPS), up 17.5% from $9.1M ($0.82) a year earlier, with nine-month net income of $29.2M, up 20.7% YoY. Net interest income rose 12.2% YoY in the quarter to $22.5M, and total assets reached $3.25B. However, credit quality weakened: non-performing loans rose to 0.58% of total loans from 0.40%, and other comprehensive loss of $11.7M in the quarter (net unrealized losses on AFS securities) pushed comprehensive income to a $1.0M loss for the quarter.

  • · Dividends declared rose to $0.38 per share in Q3 2026 from $0.37, with a 39.62% payout ratio versus 45.18% a year earlier
  • · Non-interest expense growth (6.2% YoY in the quarter) was well below revenue growth, supporting the efficiency ratio improvement
  • · Deposit growth was driven by certificates of deposit ($1.05B, up 69.6M YTD) while demand deposits grew 13.2% YoY to $316.8M
  • · Mortgage origination and servicing income was essentially flat year-to-date ($603K vs $635K, down 5.0%)
  • · Nine-month credit loss expense rose 60.6% YoY to $2.5M, and provision for loans rose 68% in the quarter ($845K vs $690K)
  • · Total investment securities were flat YoY at $643.1M, with AFS securities up 3.4% YoY but HTM securities down 2.8%
  • · Repayment of $25.0M in long-term borrowings during the nine months, reducing long-term borrowings to $70.5M
Charlton Aria Acquisition Corp 10-Q mixed materiality 6/10

05-11-2026

Charlton Aria Acquisition Corp (CHARU), a SPAC, reported Q3 2026 net income of $138,124, down 83% from $806,989 in Q3 2025, as trust income fell to $844,588 from $916,066 and formation and operating costs rose to $706,464 from $109,077, driven largely by $564,145 of professional fees tied to a potential business combination. For the nine months, net income was $1,405,762, down 39% from $2,316,270, while the trust balance grew to $93,579,630 and shareholders' deficit widened to $(4,614,552). Performance is mixed: trust assets and interest income remain stable, but expenses are sharply higher and the deficit more than doubled year over year.

  • · Redemption value per redeemable Class A share rose to $11.01 from $10.52 at Dec 31, 2025, reflecting trust accretion
  • · Two $850,000 extension deposits (June and September 2026) totaling $1,700,000 were funded, with working capital loans from a related party rising to $2,381,879
  • · Accounts payable and accrued expenses increased to $538,134 from $33,877, a key driver of the rise in total current liabilities to $2,972,836
  • · Nine-month operating cash outflow of $555,171 was funded by related-party loans of $2,280,998, leaving year-end-style cash of only $30,962
PACKAGING CORP OF AMERICA 10-Q mixed materiality 8/10

05-11-2026

Packaging Corp of America reported Q3 2026 net sales of $2,601.7 million, up 12.5% from $2,313.4 million a year earlier, and net income of $262.3 million, up 15.6% from $226.9 million. Nine-month net income declined 7.0% to $625.3 million from $672.3 million, and nine-month income from operations fell 1.2% to $927.7 million from $938.5 million as SG&A, other expense and interest costs rose sharply. Paper revenue grew only 1.3% in the quarter, while basic EPS for the nine months dropped to $7.02 from $7.48.

  • · Net sales in Q3 2026 rose 12.5% YoY while the Paper segment was essentially flat (+1.2%), with Packaging driving nearly all growth.
  • · Nine-month other expense, net nearly tripled to $99.1M from $34.7M, and nine-month interest expense more than doubled to $98.3M from $45.2M, compressing pre-tax income to $832.9M from $893.3M.
  • · Nine-month diluted EPS fell to $6.98 from $7.45 despite higher sales, and accounts receivable and inventories consumed $292.5M of operating cash.
  • · Dividends declared per share rose to $1.50 in Q3 2026 from $1.25, and $58.8M of common stock was repurchased in the nine months versus none a year earlier.
  • · The Greif Acquisition closed with total purchase consideration of $1,800.9M and goodwill of $484.0M after final allocation, with customer relationships of $420.0M and trademarks of $40.0M identified as intangibles.
MEDALLION FINANCIAL CORP 10-Q negative materiality 8/10

05-11-2026

Medallion Financial Corp. reported Q3 2026 net income attributable to the company of $2.397M, down 69% from $7.763M in Q3 2025, with diluted EPS falling to $0.10 from $0.32. Net interest income rose 4.8% YoY to $58.379M on 10.0% higher total interest income, but the provision for credit losses jumped 65.8% to $30.769M, driving income before taxes down 63.7% to $7.068M. For the nine months, net income attributable fell 52% to $14.795M while total assets grew 13.7% to $3.36B and loans rose 14.5% to $2.92B.

  • · Total other income fell 56.8% to $10.308M for nine months 2026, largely due to loss on equity investments of $0.329M vs a $15.783M gain in 2025
  • · Book value per share improved to $17.73 from $17.53 at year-end 2025
  • · Total stockholders' equity declined to $399.758M from $408.617M at December 31, 2025, while non-controlling interest rose to $151.342M from $99.429M
  • · Treasury stock repurchases rose to $13.24M in nine months 2026 from $0.986M a year earlier; shares outstanding fell to 22,550,694 from 23,311,683
  • · Salaries and employee benefits rose 9.1% to $33.046M and loan servicing fees rose 38.8% to $11.892M for nine months 2026
  • · Net cash used in investing activities was $436.664M vs $101.847M prior year, driven by loan originations of $939.978M vs $583.301M
  • · Cash and cash equivalents plus federal funds sold totaled $243.056M at September 30, 2026 vs $201.564M at year-end 2025
PERMA FIX ENVIRONMENTAL SERVICES INC 10-Q negative materiality 7/10

05-11-2026

Perma-Fix Environmental Services (PESI) reported a Q3 2026 net loss of $3.5M on net revenues of $17.9M, versus a $1.8M loss on $17.5M in Q3 2025, as gross profit fell to $0.6M from $2.6M amid a sharp rise in cost of goods sold. For the nine months, net revenues declined 8.7% to $42.0M from $46.0M and the net loss widened to $17.1M from $8.1M, though the company raised $21.1M net from a May 2026 common stock sale that lifted cash and restricted cash to $28.3M at period end.

  • · Q3 2026 cost of goods sold rose to $17.4M from $14.9M, compressing gross margin to about 3% from about 15%
  • · Nine-month gross loss of $(4.8M) compares with a $4.8M gross profit in the prior-year period, a swing of roughly $9.6M
  • · Q3 2026 research and development fell to $0.2M from $0.3M, and SG&A fell slightly to $4.0M from $4.1M, so cost cuts did not offset the margin deterioration
  • · Operating cash outflow widened to $(11.0M) from $(8.6M) for the nine months, with capital expenditures of $5.2M versus $2.6M a year earlier
  • · Accounts payable and accrued liabilities increased $5.7M in the nine months, a source of operating cash that partly offset the loss
  • · Accumulated deficit reached $(127.9M), and total liabilities rose 24.6% since year-end 2025 to $47.2M, while equity rose on the share sale
  • · Working capital is positive at $11.4M (current assets $43.9M less current liabilities $32.5M), though deferred revenue grew to $10.0M from $7.0M
  • · Weighted average basic share count rose 14.9% YoY to 21.2M, diluting per-share results after the May 2026 offering
GENESIS ENERGY LP 10-Q mixed materiality 7/10

05-11-2026

Genesis Energy LP reported Q3 2026 total revenues of $449.3M, up 8.5% YoY from $414.0M, and net income attributable to Genesis Energy, L.P. of $2.4M versus $9.2M a year earlier (down 73.8%). Nine-month revenues rose 20.0% to $1,427.8M and nine-month net income attributable to Genesis swung to $52.1M from a $460.3M loss that included a $432.2M loss on disposal of discontinued operations in 2025. Performance was mixed: offshore pipeline revenue declined 3.3% in Q3 and marine operating costs rose 19.2%, while onshore and marine revenues grew.

  • · Q3 2026 net income from continuing operations was $14.4M versus $22.8M in Q3 2025, a 36.7% decline.
  • · Net loss attributable to common unitholders in Q3 2026 was $6.3M, compared with $5.7M in Q3 2025, and basic/diluted loss per unit was $(0.05) in both periods.
  • · Senior unsecured notes were issued for $750.0M in 2026 while $679.9M of notes were repaid; $221.6M of Class A Convertible Preferred Units were redeemed.
  • · Gain on sale of assets of $17.4M was recognized in 9M 2026, and no such gain occurred in 2025.
  • · Total partners' capital fell to $93.6M at September 30, 2026 from $155.6M at December 31, 2025, and the common unitholder deficit widened to $(367.6)M.
  • · Interest expense, net was $67.3M in Q3 2026, essentially flat versus $66.4M in Q3 2025.
American Homes 4 Rent, L.P. 10-Q mixed materiality 6/10

05-11-2026

American Homes 4 Rent reported Q3 2026 rents and other single-family property revenues of $498.1 million, up 4.1% YoY from $478.5 million, and net income of $97.3 million versus $116.8 million a year earlier, a decline of 16.7%. Net income attributable to common shareholders fell 17.5% to $82.3 million, and diluted EPS was $0.23 versus $0.27, while nine-month diluted EPS rose to $0.89 from $0.85. Share count fell as the company repurchased $313.2 million of Class A common shares during the nine months, and total assets declined to $13,055.1 million from $13,242.1 million at year-end 2025.

  • · Q3 2026 gain on sale and impairment of single-family properties fell 54.8% YoY to $21.5M from $47.6M, a key driver of the net income decline
  • · Q3 2026 interest expense rose 4.6% to $50.4M from $48.2M
  • · Q3 2026 property operating expenses rose 3.5% YoY to $188.0M
  • · Nine-month 2026 operating cash flow grew 2.2% to $734.1M from $718.5M
  • · Nine-month 2026 development spending declined 28.0% to $423.5M from $587.9M
  • · Unsecured senior notes, net were $4,742.3M and revolving credit facility borrowings rose to $420.0M from $360.0M
  • · Cash and cash equivalents fell to $71.0M from $108.5M at year-end 2025
Chime Financial, Inc. 10-Q mixed materiality 8/10

05-11-2026

Chime Financial reported Q3 2026 revenue of $718.0M, up 32.1% YoY from $543.5M, driving a swing to net income of $43.7M from a $54.7M loss a year earlier. Nine-month revenue rose 28.0% to $2,035.2M while net income reached $125.0M versus a $965.2M loss, helped by a sharp drop in stock-based compensation ($204.3M vs $1,003.6M). However, operating expenses still grew 13.5% YoY in Q3 (to $611.7M) with sales and marketing up 9.7% and transaction/risk losses up 19.1%, and gross margin compressed slightly as cost of revenue rose 3.7%.

  • · Diluted EPS turned positive at $0.11 in Q3 2026 vs -$0.15 in Q3 2025; nine-month diluted EPS $0.31 vs -$5.10
  • · Member support and operations expense declined 20.4% YoY in Q3 to $104.8M from $83.7M base (nine-month fell to $309.8M from $365.4M)
  • · Technology and development expense fell 3.6% YoY in Q3 to $119.4M; nine-month dropped to $341.3M from $823.6M
  • · General and administrative expense rose 28.9% YoY in Q3 to $98.7M
  • · Nine-month operating cash flow surged to $421.0M from $20.2M
  • · Company repurchased $222.1M of common stock over nine months and drew $100.0M under a warehouse facility
  • · Accumulated deficit narrowed to $3,249.1M from $3,374.1M at year-end 2025
  • · Restricted cash jumped to $118.9M from $14.5M at Dec 31, 2025
SAUL CENTERS, INC. 10-Q mixed materiality 6/10

05-11-2026

Saul Centers reported Q3 2026 total revenue of $78.4M, up 8.9% YoY from $72.0M, driven by a 8.9% rise in rental revenue to $77.0M. However, net income fell 9.7% YoY to $12.6M and net income available to common stockholders dropped 13.2% to $6.7M ($0.27/share vs $0.32), as total expenses rose 13.5% to $65.8M on higher interest expense (+18.8% to $20.3M) and property operating costs (+15.8%). For the nine months, revenue grew 8.7% to $233.5M while net income declined 11.7% to $36.2M and EPS fell to $0.78 from $0.93.

  • · Nine months 2026 net cash provided by operating activities declined to $74.0M from $77.6M in 2025
  • · Nine months 2026 net cash used in financing activities was $32.0M vs $2.0M in 2025, reflecting higher mortgage repayments ($117.0M vs $26.6M)
  • · Construction in progress rose to $112.1M from $110.0M at year-end 2025
  • · Revolving credit facility balance decreased to $112.6M from $144.7M at December 31, 2025
  • · Distributions in excess of accumulated earnings widened to $(362.4M) from $(337.7M) at year-end 2025
  • · Q3 2026 common stock dividend was $0.59/share; Series D preferred $38.28/share and Series E $37.50/share
  • · Nine months 2026 additions to development and redevelopment projects fell to $13.3M from $52.7M in 2025
  • · Cash paid for interest rose to $57.3M from $48.6M in the prior-year nine-month period
Simpson Manufacturing Co., Inc. 10-Q mixed materiality 6/10

05-11-2026

Simpson Manufacturing reported Q3 2026 net sales of $638.1M, up 2.3% YoY from $623.5M, with net income rising 1.6% to $109.1M and diluted EPS up 3.9% to $2.68. Nine-month sales grew 5.8% to $1,897.2M and net income jumped 12.3% to $324.4M, helped by lower operating expenses and a $14.1M prior-year asset disposal gain that did not repeat. However, Q3 gross margin slipped to 45.7% from 46.1%, operating income was essentially flat (+0.2%), and comprehensive net income declined 7.0% YoY to $105.1M on unfavorable translation and hedge adjustments.

  • · Q3 2026 gross margin declined to 45.7% from 46.1% in Q3 2025 as cost of sales rose 3.2% YoY to $346.5M, outpacing 2.3% sales growth
  • · Nine-month G&A expense rose 1.8% YoY to $237.8M, the only operating expense line to increase
  • · Q3 2026 net gain on disposal of assets was only $0.07M versus $14.1M in Q3 2025, a headwind to operating income comparison
  • · Nine-month 2026 translation adjustments were a $25.5M loss versus a $64.6M gain in 2025
  • · Cash flow hedge adjustment swung to a $9.6M gain in 9M 2026 from a $39.4M loss in 9M 2025
  • · Company repurchased 881 thousand shares for $166.5M in 9M 2026 versus 522 thousand shares for $90.8M in 9M 2025
  • · Quarterly dividend raised to $0.30 per share from $0.29
  • · Cash and equivalents rose to $491.3M from $384.1M at December 31, 2025
  • · Term loan balance reduced to $288.75M from $371.25M at prior year-end; revolver drawn $19.2M
  • · Derivative liability fair value fell to $52.3M from $87.5M YoY
  • · Capital expenditures fell 64% YoY to $44.7M in 9M 2026
Cloudflare, Inc. 10-Q mixed materiality 8/10

05-11-2026

Cloudflare reported Q3 2026 revenue of $782.5M, up 39.2% YoY from $562.0M, with nine-month revenue of $2,118.3M (+36.4% YoY). However, operating losses widened sharply to $(67.9)M in Q3 (from $(37.5)M) and $(335.6)M for nine months (from $(158.0)M), driven by a $161.7M restructuring charge and heavy stock-based compensation, pushing net loss to $(34.1)M in Q3 and $(227.0)M year-to-date. The company also refinanced its 2026 convertible notes, issuing $4.44B in 2031 convertible senior notes and purchasing $259.5M in related capped calls.

  • · Q3 2026 net loss per share was $(0.10) vs $(0.00) in Q3 2025; nine-month EPS was $(0.64) vs $(0.26).
  • · Restructuring and other charges of $161.7M in nine-month 2026 (none in prior year) contributed materially to the operating loss widening.
  • · Sales and marketing grew 43.0% YoY and R&D grew 39.1% YoY in Q3, both outpacing revenue growth of 39.2%.
  • · Total current liabilities fell to $1.54B from $2.35B as the $1.29B current portion of 2026 convertible notes was repaid/refinanced.
  • · Goodwill rose to $375.8M from $226.6M, and $98.7M of common stock was issued in connection with an acquisition.
  • · Deferred revenue (current) increased to $876.8M from $684.2M at year-end 2025, signaling strong bookings momentum.
  • · Accumulated deficit deepened to $(1.43)B from $(1.20)B at December 31, 2025.
  • · Comprehensive loss was $(54.0)M in Q3 2026 vs $(3.6)M in Q3 2025.
Oscar Health, Inc. 10-Q positive materiality 8/10

05-11-2026

Oscar Health reported Q3 2026 total revenue of $5.14B, up 72% YoY from $2.99B, driven by premium revenue of $5.04B (+72% YoY). The company swung to net income of $167.3M (EPS $0.54 basic / $0.49 diluted) from a net loss of $137.5M in Q3 2025, with nine-month net income reaching $1.21B versus a $90.5M loss. However, medical costs rose 64% YoY to $4.23B and SG&A jumped 38% to $721.9M, while other revenues declined 28% YoY to $6.3M and net unrealized investment losses of $33.4M weighed on comprehensive income ($133.9M vs. a $134.8M loss prior year).

  • · Diluted weighted average shares rose to 346,457 thousand from 259,273 thousand YoY, reflecting dilution from convertible notes and equity plans
  • · Accumulated deficit narrowed to $2.09B from $3.29B at year-end 2025
  • · Payables to CMS surged to $4.63B from $2.73B at Dec 31, 2025
  • · Benefits payable increased to $1.92B from $1.46B at year-end 2025
  • · Net cash used in investing activities was $1.85B for nine months 2026 vs. $192.4M prior year
  • · Stock-based compensation expense declined to $58.9M for nine months 2026 from $69.6M
  • · Income tax expense of $49.0M for nine months 2026 vs. $5.9M prior year
  • · Comprehensive income attributable to Oscar was $133.9M in Q3 2026 vs. a $134.8M loss in Q3 2025
INSIGHT ENTERPRISES INC 10-Q mixed materiality 7/10

05-11-2026

Insight Enterprises reported Q3 2026 total net sales of $2,441.5M, up 21.8% YoY from $2,003.8M, and nine-month net sales of $6,969.0M, up 12.4% from $6,198.9M. However, Q3 net earnings fell 56.5% YoY to $22.2M (from $50.9M), diluted EPS dropped to $0.74 from $1.62, and earnings from operations declined 26.2% to $68.7M, as selling and administrative expenses rose 28.8% and severance costs more than quadrupled. Nine-month net earnings grew 23.1% to $129.7M, but the company repurchased $225.0M of stock during the period.

  • · Accounts receivable rose to $7.38B from $5.52B and accounts payable-trade rose to $5.89B from $4.26B, driving a nine-month operating cash flow of only $148.5M versus $150.1M prior year
  • · Severance and restructuring expenses were $25.7M in Q3 2026 versus $5.4M in Q3 2025 and $37.9M for nine months versus $15.8M
  • · Other income for nine months 2025 included a $25.1M warrant settlement revaluation loss that did not recur in 2026
  • · Diluted weighted average shares fell to 30.3M for nine months 2026 from 32.8M, reflecting buybacks
  • · Accumulated other comprehensive loss widened to $(49.5)M from $(36.4)M on foreign currency translation
  • · Cash and equivalents at period end were $400.9M, down from $549.4M a year earlier
Kimball Electronics, Inc. 10-Q mixed materiality 7/10

05-11-2026

Kimball Electronics reported Q1 FY2027 net sales of $390.8M, up 6.9% YoY from $365.6M, but net income fell 73.8% to $2.6M as operating income declined 14.4% to $12.4M and the effective tax rate jumped sharply (provision of $5.2M vs $0.9M). Gross margin held roughly flat at 7.9% vs 7.9%, while selling and administrative expenses rose 37.9% to $18.1M and interest expense increased 49.6% to $3.5M. The quarter included a $101.0M acquisition (net of cash) that added $44.3M of goodwill and drove total assets up 13.3% to $1,237.2M, while operating cash flow swung to a $19.3M outflow from a $8.1M inflow a year ago on inventory build.

  • · Effective tax rate rose sharply: provision of $5.2M on $7.8M pre-tax income (~66% effective rate) vs $0.9M on $11.0M prior year
  • · Restructuring expense fell to $0.4M from $1.4M YoY
  • · Non-operating expense, net widened to $1.6M from $1.2M, driven by $1.0M factoring fees
  • · Other comprehensive income swung to a $2.0M loss from a $0.4M gain, driven by foreign currency translation of -$1.4M
  • · Total debt rose to $235.4M from $116.2M at June 30, 2026, funding the acquisition
  • · Inventories increased to $312.1M from $271.9M, contributing to the operating cash outflow
  • · Capital expenditures were $9.0M vs $10.5M prior year
  • · Share owners' equity declined to $582.2M from $585.1M at June 30, 2026
  • · Repurchased 127,000 shares for $3.1M in Q1 FY2027
PIPER SANDLER COMPANIES 10-Q mixed materiality 7/10

05-11-2026

Piper Sandler Companies reported Q3 2026 net income attributable to the company of $55.4 million ($0.82 basic EPS), down from $60.3 million ($0.90 basic EPS) in Q3 2025, while net revenues fell 7.5% YoY to $443.0 million. Nine-month net income attributable to the company rose 12.6% to $188.5 million, driven by investment banking revenue up 17.5%, but Q3 investment income swung to a $13.5 million loss from a $30.6 million gain a year earlier.

  • · Q3 2026 compensation and benefits fell 0.8% YoY to $286.6M, while nine-month compensation rose 12.1% to $891.4M
  • · Accrued compensation declined from $702.8M at December 31, 2025 to $527.4M at September 30, 2026
  • · Nine-month 2026 operating cash flow was positive $94.5M versus negative $143.2M in the prior-year period
  • · Q3 2026 Income tax expense rose 6.1% YoY to $26.5M despite lower pre-tax income of $66.6M (down 38.0%)
  • · Q3 2026 Noncontrolling interests recorded a $15.3M loss versus $22.2M income in Q3 2025
REGIS CORP 10-Q mixed materiality 6/10

05-11-2026

Regis Corp reported Q1 FY2027 (quarter ended September 30, 2026) total revenue of $54.3 million, down 7.8% from $59.0 million a year earlier, with operating income falling 10.4% to $5.3 million. Net income declined 61.4% to $0.5 million ($0.21 basic EPS vs. $0.56), though diluted EPS and comprehensive income also fell, and total debt was reduced by roughly $8.5 million in the quarter. Performance was mixed: franchise rental income, royalties, and company-owned salon revenue all declined, while the balance sheet showed modest cash decline and a shrinking lease and debt base.

  • · Long-term debt was reduced by $7.9M via repayments, plus $0.6M of revolving credit facility repayments, during the quarter.
  • · Franchise rent expense and franchise rental income both declined 13.5%, indicating pass-through economics that offset each other.
  • · Gain on deferred compensation adjustment of $2.1M supported operating cash flow despite weaker earnings.
  • · Right-of-use assets fell from $175.7M to $168.7M and lease liabilities declined, reflecting a shrinking lease footprint.
  • · Broker fee asset decreased 9% to $3.7M, and total deferred revenue declined to $9.7M from $10.5M.
  • · Diluted EPS fell to $0.18 from $0.49, and diluted share count rose to 2.9M from 2.8M.
TAPESTRY, INC. 10-Q mixed materiality 8/10

05-11-2026

Tapestry, Inc. reported Q1 FY2027 (quarter ended September 26, 2026) net sales of $1,894M, up 11.1% from $1,705M a year earlier, with net income of $360M versus $275M (+30.9%) and diluted EPS of $1.76 versus $1.28 (+37.5%). Results were mixed on the balance sheet: total assets were roughly flat at $6,615M versus $6,692M, cash fell to $599M from $975M, inventories rose 27.7% to $1,055M, and stockholders' equity dropped to $344M from $692M as large share repurchases ($603M) and debt rebalancing weighed on capital.

  • · Net cash from operating activities more than doubled? No: rose 74.3% to $197M from $113M, though working capital absorbed cash via inventory (+$222M) and receivables (+$106M) build
  • · Gross margin expanded to about 78.6% from 76.3% prior year, while SG&A grew 9.4%, outpacing the 11.1% sales growth only modestly; operating margin improved to about 22.4% from 19.2%
  • · Total debt was about $2,557M, with $597M reclassified to current debt from zero at June 27, 2026, and long-term debt declining to $1,960M from $2,379M
  • · Accumulated deficit widened to $(3,545)M from $(3,210)M, reflecting repurchases recorded against retained earnings
  • · Share repurchases of $603M were 13.6% lower than the $698M in the prior-year quarter, and cash returns (buybacks plus dividends) totaled $695M
  • · Effective tax expense was $51M on $411M pre-tax income (about 12.4%), versus $44M on $319M (about 13.8%) prior year
  • · Accumulated other comprehensive loss widened to $(231)M from $(218)M, driven by foreign currency translation losses and cash flow hedge losses
Evolent Health, Inc. 10-Q mixed materiality 7/10

05-11-2026

Evolent Health reported Q3 2026 revenue of $725.4M, up roughly 51% from $479.5M a year earlier, driven by a sharp rise in cost of revenue. The company swung to an operating loss of $6.2M (vs. $0.9M operating income in Q3 2025) and a net loss attributable to common shareholders of $23.6M, though this improved from a $26.9M loss in the prior-year quarter that included preferred dividends. Nine-month revenue rose 33% to $1,874.1M, but the nine-month net loss narrowed only modestly to $78.6M from $150.3M, which included large one-time items in 2025.

  • · Operating cash flow turned positive at $16.1M for nine months 2026 vs. -$10.0M in 2025, but this was driven by a $183.9M increase in reserve for claims and performance-based arrangements, offsetting a $132.9M build in accounts receivable and contract assets.
  • · Cash and cash equivalents fell to $148.3M and restricted cash to $7.6M from $28.8M at year-end 2025, with $10M of debt repaid in 2026.
  • · Q3 2026 included no gains or losses on lease termination, contingent consideration, or refinancing, unlike Q3 2025 which had $6.0M of Series A Preferred extinguishment fees and $1.2M lease termination gain.
  • · Series A Preferred Stock was fully exchanged in 2025, so no preferred dividends were incurred in 2026 periods, contributing to the improved bottom-line comparison.
  • · Interest expense rose to $17.0M in Q3 2026 from $16.5M, and to $50.7M for nine months from $38.5M, reflecting higher debt costs following 2025 debt issuance.
Amylyx Pharmaceuticals, Inc. 10-Q mixed materiality 7/10

05-11-2026

Amylyx Pharmaceuticals reported a Q3 2026 net loss of $45.5M ($0.38 per share), versus a $34.4M loss in Q3 2025, as operating expenses rose 38% to $49.7M on higher R&D ($28.4M vs. $19.9M) and SG&A ($21.3M vs. $16.2M). Nine-month net loss widened to $130.2M from $111.7M, though cash, cash equivalents and marketable securities increased sharply to $768.1M at September 30, 2026, following a $544.6M financing in Q3. Net loss per share improved to $(1.15) from $(1.25) year-to-date, reflecting the much larger weighted-average share count.

  • · Q3 2026 IPR&D milestone charge of $4.0M, with matching milestone payment in investing activities
  • · Available-for-sale securities posted a $386K net unrealized loss for the nine months ended September 30, 2026
  • · Nine-month net cash used in operating activities widened to $102.0M from $95.4M
  • · Nine-month proceeds from option exercises and RSU vesting rose to $20.8M from $3.7M
  • · Stock-based compensation expense for the nine months was $24.8M versus $21.3M a year earlier
  • · Q3 2026 interest income rose to $4.2M from $1.8M, offsetting part of the larger operating loss
  • · Total stockholders' equity increased to $753.7M from $305.3M at year-end 2025
  • · Shares outstanding grew about 17% to 128.5M since December 31, 2025
Cartesian Therapeutics, Inc. 10-Q mixed materiality 7/10

05-11-2026

Cartesian Therapeutics reported a Q3 2026 net loss of $11.5M, narrowing sharply from a $35.9M loss in Q3 2025, driven primarily by a $10.7M gain on the change in fair value of its contingent value rights (CVR) liability, which offset $15.6M of R&D expense. However, the company generated no revenue in the quarter versus $0.5M a year earlier, cash and equivalents declined to $123.0M from $125.1M at year-end 2025, and stockholders' deficit widened to $(130.5)M from $(126.2)M, with the company newly carrying $50.2M of long-term debt.

  • · Net cash used in operating activities widened to $70.9M for nine months 2026 from $56.2M in the prior-year period
  • · Purchases of property and equipment fell to $0.7M from $5.0M year over year
  • · Accounts receivable fell to $0.05M from $1.1M at year-end 2025
  • · Q3 2026 net loss per share of $(0.38) compares with $(1.38) in Q3 2025, reflecting both lower loss and a 16.5% increase in weighted-average shares
  • · Q3 2026 interest expense of $2.0M reflects the new long-term debt
  • · Derivative liability embedded in long-term debt was $8.6M at September 30, 2026, classified as Level 3
  • · Series A Preferred shares outstanding declined from 120,790 to 98,050 following conversions into common stock
  • · Nine-month 2026 operating loss of $80.7M compares with $64.8M, driven by higher R&D spending
Duke Energy CORP 10-Q mixed materiality 8/10

05-11-2026

Duke Energy's Q3 2026 10-Q shows total operating revenues of $9,104 million for the three months ended September 30, 2026, up 6.6% from $8,542 million a year earlier, and net income available to common stockholders of $1,551 million (EPS $1.99 vs. $1.81, +9.9%). Nine-month results were also higher, with operating revenues of $25,874 million (+6.5% YoY) and EPS of $5.34 (vs. $4.81), though this was helped by a $368 million gain on the sale of Piedmont's Tennessee business. Performance was mixed: operation, maintenance and other expense fell 22% in the quarter, while fuel and purchased power costs rose 19.6% and interest expense rose 7.2%.

  • · Operating cash flow fell 9.0% to $7,889 Million in the nine months, while capital expenditures rose 27.2% to $12,566 Million, widening the funding gap that was partly covered by $2,839 Million of NCI contributions and $9,554 Million of new long-term debt issuance.
  • · Long-term debt rose to $84,332 Million from $80,108 Million at year-end 2025, and total equity rose to $57,542 Million, supported by the NCI contributions.
  • · Regulated natural gas revenue was roughly flat in Q3 (down 0.8%) and nonregulated electric and other revenue declined 6.8%.
  • · Q3 2026 included a $(2) Million benefit in impairment and other charges, versus no charge in Q3 2025, while nine-month impairments were $47 Million.
  • · Cash and cash equivalents increased to $451 Million from $245 Million at year-end 2025.
Core Natural Resources, Inc. 10-Q mixed materiality 7/10

05-11-2026

Core Natural Resources reported Q3 2026 revenues of $1,145,087K, up 14.2% YoY from $1,002,543K, and net income of $8,998K versus $31,598K in Q3 2025, a 71.5% decline. For the nine months, revenues rose 7.9% to $3,370,379K and net income swung to $156,509K from a net loss of $(74,235)K, while diluted EPS was $3.11 versus $(1.44). Performance was mixed: top-line and nine-month profitability improved, but quarterly net income fell, General and Administrative costs were cut 26.4% in Q3, and cash from operations rose while cash and equivalents declined modestly.

  • · Q3 2026 operating income of $6,682K reversed a $(11,810)K operating loss in Q3 2025, though pre-tax result was a $(3,581)K loss versus $(21,400)K a year earlier.
  • · Q3 2026 income tax was a $(12,579)K benefit versus a $(52,998)K benefit in Q3 2025, flattering the net result relative to the pre-tax line.
  • · Interest expense rose to $33,135K for nine months from $28,676K, while interest income fell to $14,950K from $20,297K.
  • · Other Operating Income and Expense was a $(100,360)K charge for nine months 2026 versus $(3,169)K in 2025, a major drag on operating results.
  • · Total liabilities declined to $2,419,571K from $2,451,819K, and long-term debt rose to $403,150K from $354,160K while current debt fell to $52,474K.
  • · Share repurchases totaled roughly $189.6M in cash for nine months 2026 across 2.1M+ shares retired, while quarterly dividends held at $0.10 per share.
  • · Pension and postretirement non-service costs were $(16,963)K for nine months 2026 versus $(19,301)K in 2025.
CENTRUS ENERGY CORP 10-Q mixed materiality 7/10

05-11-2026

Centrus Energy's Q3 2026 10-Q shows a mixed quarter: Q3 total revenue fell 25.9% YoY to $55.5M from $74.9M and the company posted an operating loss of $29.7M versus $16.6M a year earlier, with gross loss widening to $10.6M. However, net income rose to $31.6M from $3.9M, driven primarily by a $46.4M non-cash gain on change in fair value of the warrant liability. For the nine months, revenue rose 1.9% to $308.3M and net income was $58.4M versus $60.0M, while operating loss swung to $18.5M from operating income of $37.4M.

  • · Nine-month cash used in operating activities was $11.1M versus $99.4M provided in the prior-year period, driven by a $138.7M outflow from inventories owed to customers and suppliers.
  • · Capital expenditures rose to $226.4M for nine months 2026 from $10.1M a year earlier, reflecting the domestic enrichment expansion.
  • · Cash and cash equivalents of $2,236.1M at September 30, 2026 versus $1,957.2M at December 31, 2025, supported by $493.8M of net proceeds from warrant and pre-funded warrant issuance.
  • · U.S. SWU and uranium revenue fell to $84.4M for nine months from $142.5M, while foreign revenue rose to $145.4M from $79.3M.
  • · Stockholders' equity increased to $1,105.1M from $765.1M, and equity-related compensation expense was $16.8M versus $5.3M.
Unity Software Inc. 10-Q mixed materiality 8/10

05-11-2026

Unity Software Inc. reported Q3 2026 revenue of $622.1M, up 32.2% YoY from $470.6M, and swung to net income of $121.6M from a net loss of $126.8M in Q3 2025. Nine-month results remain weaker: revenue rose 24.5% to $1,676.8M, but the net loss narrowed only modestly to $248.0M from $312.1M, and cost of revenue jumped 65.2% to $575.9M, compressing nine-month gross profit by 9.4%. Q3 gross profit rose 45.5%, but nine-month gross profit fell from $998.1M to $1,100.9M (an increase, not a decline, on the figures as reported; see note below).

  • · Nine-month cost of revenue surged 65.2% to $575.9M, while Q3 cost of revenue was roughly flat, implying a heavy concentration of cost in the first half of 2026.
  • · Nine-month impairment of intangible assets of $270.5M and impairment of investments of $15.0M weighed on results; intangible assets, net fell from $650.5M to $86.4M.
  • · Nine-month operating cash flow rose 66.1% to $500.9M, though accounts receivable increased $207.6M, a material use of working capital.
  • · Sales and marketing expense fell 37.6% YoY in Q3 to $103.5M, a key driver of the Q3 operating turnaround, while R&D rose 2.8% to $251.1M.
  • · Nine-month interest income and other income declined 50.5% to $45.7M, reducing non-operating support to earnings.
  • · Share count rose about 2.6% since year-end (432.9M to 443.8M) from employee equity plans and RSU settlements, adding dilution pressure.
  • · Convertible notes total approximately $2.24B ($557.5M current plus $1,680.9M non-current) against $2.65B of cash and equivalents.
Commerce.com, Inc. 10-Q mixed materiality 6/10

05-11-2026

Commerce.com, Inc. (CMRC) reported Q3 2026 revenue of $84.2M, down 2.1% YoY from $86.0M, and a net loss of $3.2M versus a $2.2M loss a year earlier. Nine-month revenue rose 1.1% to $255.6M and nine-month net income turned positive at $1.6M versus a $11.0M loss in the prior-year period, though operating income for the quarter was negative at $(1.8)M. Cash and equivalents climbed to $92.5M from $44.3M at year-end 2025, while total stockholders' equity rose to $52.3M.

  • · Gross margin fell to roughly 74% in Q3 2026 from roughly 78% in Q3 2025 as cost of revenue rose 17.5% while revenue declined
  • · Research and development expense was flat for the nine months (about $55.1M vs $55.0M) and rose 11% in Q3
  • · General and administrative expense rose 13.6% in Q3 2026 to $13.8M from $12.1M
  • · Deferred revenue grew to $68.8M from $59.6M at year-end 2025, a 15.5% increase
  • · Accumulated deficit narrowed to $(639.4)M from $(641.0)M at year-end 2025
  • · Q3 2026 operating cash flow of $9.4M was below the $10.6M generated in Q3 2025, though nine-month operating cash flow rose 34% to $32.8M
  • · Marketable securities declined to $69.1M from $96.8M at year-end 2025 as cash was redeployed
Korro Bio, Inc. 10-Q mixed materiality 6/10

05-11-2026

Korro Bio reported a Q3 2026 net loss of $17.5M (vs. $18.1M in Q3 2025), a 2.9% improvement, with no collaboration revenue in the quarter versus $1.1M a year earlier. Nine-month net loss narrowed to $56.1M from $67.2M (-16.6%), supported by lower R&D spend, while cash, equivalents and marketable securities rose to $124.8M (from $85.2M at year-end 2025) following an $80.3M private placement and $5.0M in at-the-market issuances.

  • · Collaboration revenue fell to zero in both Q3 and nine-month 2026, versus $1.1M and $5.1M in the prior-year periods, indicating no collaboration income this year.
  • · Accumulated deficit reached $439.9M, up from $383.8M at December 31, 2025.
  • · Operating lease liabilities (current and non-current) total $41.5M at September 30, 2026, a significant long-term obligation.
  • · Deferred revenue declined to $7.8M in total ($3.0M current plus $4.8M non-current) from $7.8M at year-end 2025 with the non-current portion down $3.0M.
  • · Depreciation expense fell 70% for nine months ($1.1M vs $3.6M), and property and equipment, net, declined to $7.2M from $8.2M.
  • · Restricted cash ($2.4M) fell from $3.4M at year-end 2025, and total cash, equivalents and restricted cash reached $42.6M.
  • · Net cash from financing was $85.3M in 2026 versus $0.3M in 2025, while investing used $21.9M compared with $29.1M provided in 2025.
  • · Treasury stock of $12.1M was recorded for 1,000,000 shares exchanged into pre-funded warrants in Q3 2026.
  • · Level 3 liabilities include a $1.5M CVR liability, offset by a matching $1.5M MS APA financial asset.
GigaCloud Technology Inc 10-Q mixed materiality 7/10

05-11-2026

GigaCloud Technology's Q3 2026 10-Q reports total revenues of $423.6M for the three months ended September 30, 2026, up 27.3% YoY from $332.6M, and net income of $50.6M, up 36.1% from $37.2M. Nine-month revenues reached $1,194.7M (up 28.9% YoY) with net income of $131.1M (up 32.6%). Growth was not uniform: service revenues rose 25.5% in the quarter, while nine-month comprehensive income was dampened by a $2.0M intra-entity FX loss and a $1.5M swing to other comprehensive loss, and treasury share repurchases of $60.0M were executed during the nine months.

  • · Comprehensive income for nine months fell 19.0% YoY to $129,540K despite net income rising 32.6%, due to a $1,527K other comprehensive loss versus a $5,995K gain in the prior year
  • · Intra-entity foreign currency transactions swung to a $2,002K loss for nine months from a $4,602K gain in 2025
  • · Foreign currency exchange results turned to a $1,718K loss for nine months versus a $882K gain in 2025
  • · Cash and cash equivalents declined 1.5% from $379,780K at year-end 2025 to $374,212K despite strong earnings, reflecting working capital and buyback outflows
  • · Accounts payable fell 18.5% to $85,922K from $105,407K at year-end 2025, while inventories rose 16.3% to $218,982K
  • · Other non-operating income, net dropped 77.5% for nine months to $1,354K from $3,494K
  • · Diluted weighted average shares declined 5.8% for nine months as buybacks reduced the share count, supporting per-share growth
BeOne Medicines Ltd. 10-Q mixed materiality 7/10

05-11-2026

BeOne Medicines reported Q3 2026 net income of $384.7M (vs. $124.8M in Q3 2025) and nine-month net income of $849.1M (vs. $220.4M), with cash and equivalents rising to $5,781.1M from $4,547.5M at year-end 2025. Growth was not uniform: total other revenue rose to $34.8M in the quarter from $17.3M, yet R&D expense fell sharply to $6.0M from $30.1M, and PP&E and accounts payable were roughly flat year over year.

  • · Nine-month sale of future royalties proceeds of $885.0M in 2025 did not recur in 2026; 2026 financing inflows were only $164.8M, with option exercises and ESPP contributing $145.0M
  • · Research and development cost share liability was fully amortized to zero by September 30, 2026 (from $64.3M), and nine-month R&D expense fell to $65.7M from $77.2M
  • · Short-term debt rose to $248.9M from $57.3M while long-term debt declined to $825.2M from $961.9M
  • · Interest expense paid rose to $92.0M for nine months from $36.1M, and income taxes paid rose to $157.0M from $80.0M
  • · Accumulated other comprehensive loss narrowed to $(6.6)M from $(78.2)M, aided by foreign currency translation gains of $70.9M for nine months
  • · Share-based compensation totaled $393.2M for nine months, roughly flat versus $387.1M a year earlier
HAEMONETICS CORP 10-Q mixed materiality 7/10

05-11-2026

Haemonetics reported Q2 FY2027 (three months ended September 26, 2026) net revenues of $357.8M, up 9.3% YoY from $327.3M, with net income rising to $46.3M from $38.7M and diluted EPS of $1.00 versus $0.81. Six-month revenue reached $697.1M (+7.5% YoY) and six-month net income was $79.3M (+9.1%). However, growth was uneven: Q2 comprehensive income was $49.2M versus $34.4M, but six-month comprehensive income fell to $78.2M from $87.3M due to a swing in foreign currency translation, and operating cash flow, while higher at $180.4M versus $128.7M, was accompanied by a rise in long-term debt reduction activity and a $75.0M share repurchase in the prior-year period with none in the current period.

  • · Six-month comprehensive income declined to $78.2M from $87.3M despite higher net income, driven by a swing in foreign currency translation from a $14.9M gain to a $3.2M loss.
  • · Q2 SG&A grew 10.6% YoY to $118.4M, outpacing revenue growth of 9.3%.
  • · Q2 amortization of acquired intangibles fell 7.0% YoY and Q2 included no impairment, versus an $8.6M intangible impairment in the prior-year quarter.
  • · Interest and other expense rose to $22.1M for six months from $15.9M, a 39% increase that compressed pre-tax income growth.
  • · Long-term debt fell to $1,114.1M from $1,219.6M, reflecting a $100.0M revolver paydown, while $17.6M of contingent consideration was paid.
  • · A January 9, 2026 acquisition added $117.1M of developed technology and $52.1M of goodwill, with net assets acquired of $166.0M, financed alongside a $75.0M prior-year buyback that was not repeated this period.
Arhaus, Inc. 10-Q mixed materiality 6/10

05-11-2026

Arhaus, Inc. reported Q3 2026 net revenue of $368.1 Million, up 6.8% YoY from $344.6 Million, while net income fell 36.0% to $7.8 Million from $12.2 Million as SG&A grew faster than gross margin. For the nine months ended September 30, 2026, net revenue rose 5.2% to $1,067.3 Million and net income declined 4.7% to $49.7 Million, with diluted EPS flat at $0.35 versus $0.37 a year earlier on a basic basis.

  • · Client deposits rose to $325.0M from $235.9M at year-end 2025, a 37.7% increase, which supports operating cash flow
  • · Dividend payments of $49.6M in the nine months consumed most of the net income, versus $0.3M paid in the prior-year period
  • · Q3 2026 gross margin rose 8.3% YoY to $144.4M, but SG&A grew 14.8% to $134.3M, compressing operating margin to 2.7% from 4.8%
  • · Operating lease costs rose 17.9% for the nine months to $61.1M, and merchandise inventory increased to $360.5M from $338.8M
  • · Three new accounting standards (ASU 2024-03, ASU 2025-01, ASU 2025-06) are pending, with adoption in fiscal 2027 and 2028
CITIZENS FINANCIAL SERVICES INC 10-Q mixed materiality 7/10

05-11-2026

Citizens Financial Services (CZFS) reported Q3 2026 net income of $11.9M ($2.48 diluted EPS), up 19.2% from $10.0M ($2.09) a year earlier, and nine-month net income of $32.5M ($6.77 EPS), up 24.5% YoY. Net interest income rose 8.4% in the quarter to $27.3M and total assets grew 11.4% to $3.41B. However, comprehensive income fell sharply to $0.8M from $16.4M due to a $11.2M after-tax decline in unrealized securities values, and non-interest expenses rose 5.8% while the Q3 provision for credit losses dropped to zero from $0.5M.

  • · Student loans held for sale rose to $245.3M from $79.4M at December 31, 2025, a more than threefold increase.
  • · Borrowed funds increased to $512.5M from $309.4M, up 65.6% since year-end 2025.
  • · Noninterest-bearing deposits declined 1.3% since December 31, 2025, while interest-bearing deposits grew 7.5%.
  • · Other real estate owned expenses rose to $422K in Q3 2026 from $6K a year earlier, and to $812K for nine months from $198K.
  • · Service charges and trust fees grew modestly, but brokerage and insurance income fell 18.1% YoY in Q3 and 11.5% over nine months.
  • · Bank owned life insurance balance increased to $75.1M from $51.5M, and earnings on BOLI rose 83.2% YoY for nine months.
  • · FDIC insurance expense declined 11.6% for nine months ($1.185M vs. $1.340M) despite balance sheet growth.
  • · Nine-month net interest income growth of 10.1% contrasted with a Q3 growth rate of 8.4%, reflecting a slower quarterly pace.
  • · Q3 2026 dividend of $0.510 per share was up from $0.500 a year earlier, while nine-month dividends totaled $1.520 per share.
  • · Cash flow from operations rose to $23.2M from $19.8M for the nine months, while net cash used in investing activities reached $357.8M.
Eve Holding, Inc. 10-Q negative materiality 8/10

05-11-2026

Eve Holding, Inc. reported a Q3 2026 net loss of $58.1 million (vs. $46.9 million in Q3 2025, a 23.9% increase) and a nine-month net loss of $161.1 million (vs. $160.3 million, a 0.5% increase). Total shareholders' equity turned negative at $(34.5) million as of September 30, 2026, down from $123.8 million at December 31, 2025, while long-term debt rose to $313.6 million from $176.4 million. Cash and cash equivalents increased to $119.4 million from $103.2 million, but net cash used by operating activities widened to $166.9 million from $134.5 million for the nine months.

  • · Q3 2026 gain from warrant liability fell to $1.0M from $6.4M in Q3 2025, reducing the offset to operating losses
  • · Financial investment income rose 2.7% in Q3 to $4.3M and 21.2% for nine months to $14.1M
  • · Income tax expense for nine months was $0.2M versus $1.1M in the prior year; Q3 expense was $3.0M versus $1.2M
  • · Fixed deposits rose to $116.2M from $30.1M, while cash held directly fell to $2.4M from $71.4M
  • · Net proceeds from debt of $192.7M against $52.8M of principal repayments drove a net debt increase of roughly $140M in nine months
  • · Property, plant and equipment, net increased 40.8% to $14.9M, with construction in process up to $6.8M
  • · Capitalized software, net increased 88.5% to $9.0M
Yum China Holdings, Inc. 10-Q mixed materiality 7/10

05-11-2026

Yum China reported Q3 2026 total revenues of $3,477 Million, up 8.5% YoY from $3,206 Million, and net income attributable to Yum China of $311 Million, up 10.3% from $282 Million. Diluted EPS rose to $0.91 from $0.76, helped by a 7.0% reduction in diluted weighted-average shares (343 Million vs. 369 Million). However, year-to-date free cash flow was pressured by a $1,202 Million intangible asset acquisition, and short-term borrowings rose sharply to $1,549 Million from $30 Million, while cash and cash equivalents only increased modestly to $535 Million.

  • · Company restaurant expenses rose 6.5% YoY to $2,640 Million, growing slower than company sales (+7.2%), supporting margin expansion
  • · Operating profit margin in Q3 2026 was approximately 13.0% (451/3,477) vs 12.5% in Q3 2025
  • · YTD 2026 Acquisition of intangible assets of $1,202 Million, funded largely by $1,561 Million in short-term borrowings, with intangible assets, net rising to $1,416 Million from $148 Million
  • · Q3 2026 dividend declared at $0.29 per share, up from $0.24 per share in Q3 2025 (+20.8%)
  • · Q3 2026 share repurchases totaled $265 Million (6 Million shares) versus $329 Million in Q3 2025
  • · Non-current operating lease liabilities declined to $1,709 Million from $1,823 Million; YTD changes in non-current operating lease liabilities were a $275 Million cash outflow
  • · Dividends paid to noncontrolling interests rose to $63 Million YTD from $31 Million, roughly doubling YoY
  • · Interest income fell 69.6% YoY in Q3 2026 to $7 Million from $23 Million, reflecting lower interest-earning balances or rates
  • · Q3 2026 Pizza Hut segment revenue of $665 Million vs KFC segment revenue of $2,597 Million; All Other Segments revenue of $307 Million
  • · Total liabilities increased to $6,311 Million from $4,684 Million, driven by the rise in short-term borrowings
NewLake Capital Partners, Inc. 10-Q negative materiality 6/10

05-11-2026

NewLake Capital Partners reported Q3 2026 total revenue of $12.0M, down 4.5% YoY from $12.6M, and net income attributable to common stockholders of $4.2M ($0.20 per diluted share) versus $6.7M ($0.32) a year earlier, a 37% decline. Nine-month revenue fell 6.0% to $36.4M and net income attributable to common stockholders fell 21.9% to $15.8M, driven by a 79% jump in quarterly D&A to $5.7M and a 2.2% rise in total G&A. Cash fell to $17.9M after the company repaid its $7.6M revolver, while the accumulated deficit widened to $70.4M.

  • · Q3 2026 depreciation and amortization rose 47.8% YoY (5,724 vs 3,874), a major driver of the lower net income, which the summary covers only as a 79% figure in the derived comparison
  • · Q3 2026 property carrying costs rose to $276K from $145K (+90%) and nine-month carrying costs to $643K from $150K
  • · Fees and reimbursables fell 49.6% YoY in Q3 (58 vs 115) and 24.7% for nine months (629 vs 835)
  • · Rental income declined 3.8% YoY in Q3 (11,828 vs 12,335) and 5.7% for nine months (35,376 vs 37,485)
  • · Interest expense fell to $146K from $232K in Q3, a 16.8% decline, as the revolver was fully repaid
  • · Real estate held for sale and loan receivable were broadly flat, with the loan receivable reduced by a $250K principal repayment
  • · Accumulated deficit widened to $70.4M from $59.4M at year-end 2025 as dividends exceeded earnings
  • · Net income attributable to common stockholders covered nine-month common dividends of $26.5M only partially (about 60%), a coverage ratio worth monitoring
Evergy, Inc. 10-Q mixed materiality 7/10

05-11-2026

Evergy, Inc. filed its Form 10-Q for the quarter ended September 30, 2026. Q3 2026 operating revenues rose 15.8% year-over-year to $2,096.6 million and net income attributable to Evergy increased 29.0% to $612.9 million, while year-to-date diluted EPS reached $4.14 versus $3.31. However, cash flow from operations was roughly flat (down 0.7% YTD to $1,699.2 million), net cash used in investing rose 30.6% to $2,484.9 million on heavier capital spending, and Q3 interest expense climbed 10.5% to $168.0 million.

  • · Other income rose to $62.7 million YTD from $31.5 million, driven by corporate-owned life insurance income of $24.4 million versus $8.3 million a year earlier.
  • · Income tax expense rose to $67.3 million YTD from $45.6 million, despite higher pre-tax income.
  • · Issuance of common stock brought in $322.2 million YTD versus $0.8 million, and long-term debt proceeds were $2,308.1 million versus $1,012.7 million, funding the capital program.
  • · Short-term debt was reduced by $620.2 million YTD, and commercial paper fell to $780.9 million from $1,394.0 million at year-end 2025.
  • · Current maturities of long-term debt jumped to $1,495.3 million from $367.0 million at December 31, 2025, creating near-term refinancing needs.
  • · Accounts receivable increased to $549.9 million from $214.2 million at year-end 2025.
  • · Accrued taxes rose to $388.3 million from $169.4 million at year-end 2025.
  • · Dividends paid were $473.1 million YTD versus $455.7 million, with the quarterly dividend held at $0.6675 per share.
  • · Gains on early-stage clean energy investments were $7.3 million YTD, compared with losses of $29.0 million a year earlier.
Snap Inc 10-Q mixed materiality 7/10

05-11-2026

Snap Inc. reported Q3 2026 revenue of $1,722.5 Million, up 14.3% YoY from $1,506.8 Million, and swung to net income of $56.5 Million from a net loss of $103.5 Million in Q3 2025. However, operating expenses rose faster than revenue, with research and development up 5.3% and sales and marketing up 16.3% YoY, and nine-month net loss narrowed only to $196.4 Million from $505.7 Million while cash used in financing rose substantially on share repurchases.

  • · Other revenue, which includes subscription products, grew 84.4% YoY to $349.7 Million and now represents about 20% of Q3 2026 revenue, while advertising revenue grew only 4.2%.
  • · Q3 2026 net income of $56.5 Million was driven in part by $27.0 Million lower G&A expense; however, Q3 2026 other income (expense), net was essentially break-even at $(0.04) Million versus $27.6 Million a year earlier.
  • · Nine-month 2026 repurchases of Class A stock totaled $601.0 Million, exceeding nine-month operating cash flow of $713.5 Million only partially, with cash, equivalents and marketable securities declining to about $2.77 Billion from $2.94 Billion at December 31, 2025.
  • · Accumulated deficit widened to $(14,744.2) Million at Sept 30, 2026 from $(13,946.8) Million at Dec 31, 2025, reflecting the nine-month net loss and retired repurchased shares.
  • · Nine-month 2026 operating loss of $(168.5) Million remained negative, and interest expense rose to $(111.0) Million from $(85.5) Million year over year.
  • · Current debt rose to $106.2 Million from $47.0 Million, and Q3 2026 included $47.0 Million of convertible note repayments.
Lyntris Inc. 10-Q mixed materiality 8/10

05-11-2026

Lyntris Inc. reported Q3 2026 revenue of $194.4M, up 90.4% YoY from $102.1M, and nine-month revenue of $435.4M, up 54.9% from $281.2M, with gross profit rising 56.4% for the quarter. However, the company remained loss-making: Q3 net loss was $3.0M (vs. $3.5M a year earlier, an improvement of about 12.8%), while nine-month net loss widened 36.8% to $18.0M from $13.2M, driven by a $7.4M loss on extinguishment of debt. Operating income for the nine months declined 7.3% YoY to $12.1M, and Q3 operating income more than doubled to $11.1M from $5.7M.

  • · Nine-month operating cash flow swung to +$118.9M from -$16.8M a year earlier, though supported by a $48.4M increase in deferred revenue and a $56.4M increase in other current liabilities.
  • · Total debt was reduced sharply: long-term debt (net of current portion) fell to $190.5M from $281.1M at year-end 2025, while current liabilities rose to $234.2M from $100.5M.
  • · Air & Missile Defense revenue grew only about 8% for nine months (to $154.1M from $103.5M in absolute terms), lagging the other two segments, which grew roughly 52–55%.
  • · Inventory increased 64% to $29.4M and other current assets nearly doubled to $48.4M since year-end 2025.
  • · Equity-based compensation of $15.2M in 2026 (vs. $0.8M in 2025) contributed to the increase in additional paid-in capital to $220.9M.
  • · Q3 2026 other expense of $7.4M was entirely attributable to a loss on extinguishment of debt, which was the primary driver of the Q3 pre-tax loss despite higher operating income.
Traeger, Inc. 10-Q mixed materiality 8/10

05-11-2026

Traeger, Inc. reported Q3 2026 revenue of $74.7M, down 40.4% from $125.4M in Q3 2025, and a net loss of $28.5M versus $89.8M a year earlier (which included a $74.7M goodwill impairment). For the nine months, revenue fell 30.3% to $288.9M and the net loss narrowed to $34.2M from $98.0M. Operating cash flow improved to $54.8M from $5.0M, and cash rose to $67.8M, though revenue contraction remains severe across all product categories.

  • · Q3 2026 gross margin was approximately 33.5%, down from 38.7% in Q3 2025, indicating margin compression alongside falling revenue.
  • · Operating loss narrowed to $19.8M in Q3 2026 from $83.4M in Q3 2025, but the prior-year figure was inflated by the $74.7M goodwill impairment.
  • · Sales and marketing expense fell 28.5% YoY in Q3 2026 to $14.3M, and general and administrative expense fell 10.0% to $19.9M.
  • · Restructuring and other costs were $1.7M in Q3 2026, down from $6.2M in Q3 2025, but rose to $6.4M for nine months versus $9.7M prior-year.
  • · Accounts receivable declined from $82.1M at December 31, 2025 to $45.3M at September 30, 2026, a 44.8% reduction contributing to operating cash flow.
  • · Inventories fell from $98.8M to $79.5M since year-end 2025, a 19.6% reduction.
  • · Total stockholders' equity declined 18.0% year to date to $140.0M, driven by the accumulated deficit increase to $838.2M.
  • · Notes payable total approximately $400.7M including current portion, against cash of $67.8M, leaving leverage relatively high versus a shrinking revenue base.
  • · Comprehensive loss for nine months 2026 was $34.8M, compared with $100.9M in the prior-year period.
  • · Intangible assets of $357.4M represent 57% of total assets, creating a risk of future impairment given revenue declines.
INSEEGO CORP. 10-Q negative materiality 8/10

05-11-2026

Inseego Corp. reported Q3 2026 total revenues of $33.3 million, down 27.5% from $45.9 million in Q3 2025, and a net loss of $8.1 million versus net income of $1.4 million a year earlier. Nine-month revenues declined 5.3% to $111.6 million and the nine-month net loss widened to $21.1 million. Fixed wireless access revenue fell sharply (-76.3% in Q3), while mobile solutions revenue rose 19.1%. Stockholders' deficit deepened to $36.6 million, and cash fell to $6.6 million from $24.9 million at year-end 2025.

  • · Gross margin compressed to roughly 33% in Q3 2026 from roughly 42% in Q3 2025, with gross profit down 41.9% YoY.
  • · Operating loss of $17.975M for nine months 2026 versus operating income of $3.0M a year earlier, driven by higher G&A (up 40.1%) and R&D.
  • · Nine-month operating cash outflow of $9.2M and investing outflow of $10.6M, funded by Working Capital Facility draws of $16.65M (net $7.6M outstanding) and a $6.7M cash payment in the preferred stock exchange.
  • · Preferred stock exchange removed $42.0M carrying value of preferred stock and added a $15.1M deemed contribution to equity, with $23.5M of fair value in common stock, debt and cash payables issued.
  • · Inventory rose to $20.5M from $7.7M at year-end 2025 while accounts payable rose to $36.9M from $23.6M, indicating working capital pressure.
  • · Total liabilities of $131.3M exceed total assets of $94.7M, reflecting the stockholders' deficit.
CION Investment Corp 10-Q negative materiality 8/10

05-11-2026

CION Investment Corp reported a net decrease in net assets from operations of $3.6 million ($0.07 per share) for the quarter ended September 30, 2026, versus a $35.9 million increase ($0.69 per share) in the prior-year quarter, a decline of roughly 110%. Total investment income fell 38.6% YoY to $48.3 million, while net investment income after taxes dropped 68.0% to $12.3 million ($0.25 per share vs. $0.74). Net asset value per share declined to $13.20 from $13.76 at December 31, 2025, and total investments at fair value fell 17.2% to $1,501.7 million, though cash and short-term investment positioning improved and financing arrangements were reduced by $241.3 million since year-end.

  • · Net realized losses for the nine months were $26.9M versus $39.7M a year earlier, while net change in unrealized depreciation was $8.1M versus $14.6M.
  • · Controlled investments fair value rose to $384.9M from $289.7M at year-end 2025, but Q3 2026 controlled investment interest income fell 67.8% YoY to $6.3M and controlled fee income went to zero.
  • · Non-controlled, non-affiliated investments fair value declined to $684.1M from $1,159.0M at year-end 2025 (-41.0%), reflecting heavy portfolio runoff.
  • · Nine-month proceeds from principal repayments were $198.8M and proceeds from sales were $203.7M, versus $270.1M and $18.5M in 2025.
  • · Net asset value fell to $649.5M from $707.6M at year-end, with accumulated distributable losses widening to $(337.4)M from $(296.9)M.
  • · Financing arrangements were reduced by $364.8M in Q3 2026 alone, funded partly by $87.0M of new borrowings and the sale or restructuring of portfolio assets.
  • · Investments sold to SLFP in exchange for common SLFP LLC interests totaled $47.8M in Q3 2026 and nine months 2026.
  • · Leverage ratio implied by the schedule: total investments of $1,501.7M against net assets of $649.5M represents roughly 231% of net assets, with liabilities in excess of other assets at (131.2)% of net assets.
  • · Several equity positions carry zero fair value at September 30, 2026, including STATinMed Parent Class A and Class B Preferred Units, TG Parent NewCo Common Units, and Sopris Topco Common Units.
Pattern Group Inc. 10-Q mixed materiality 8/10

05-11-2026

Pattern Group Inc. (PTRN) reported Q3 2026 revenue of $885.8M, up 38.5% YoY from $639.7M, and net income of $32.1M versus a net loss of $59.1M in Q3 2025. For the nine months, revenue rose 42.7% to $2,536.3M and net income swung to $88.8M from a $12.5M loss. However, growth was uneven: the Amazon.com channel grew 34.5% for the quarter, while the Amazon marketplaces international channel grew 37.9% and the SaaS, logistics and other segment grew 136% from a small base. Inventory rose 24.8% since year-end 2025 to $367.6M, and operating cash flow was supported by a $48.9M increase in accounts payable.

  • · Other comprehensive income was negligible at $154K in Q3 2026 and $(75)K for nine months, reflecting minimal foreign currency translation exposure
  • · Series B Preferred Stock redemption in 2025 resulted in a $231.3M deemed dividend that drove a large Q3 2025 loss to common stockholders of $(223.0)M
  • · Cash paid for income taxes fell to $9.7M for nine months 2026 from $18.0M in the prior-year period
  • · Stock-based compensation fell to $31.2M for nine months 2026 from $84.7M, a sharp decline
  • · Property and equipment, net rose 42.1% to $58.4M since year-end 2025, consistent with rising capital expenditures
  • · International revenue grew 39.2% YoY in Q3 2026 to $106.1M, outpacing U.S. growth of 36.4%
WaterBridge Infrastructure LLC 10-Q mixed materiality 8/10

05-11-2026

WaterBridge Infrastructure LLC (WBI) reported Q3 2026 total revenues of $240.2M, up 94.9% from $123.3M in Q3 2025, and net income of $13.3M versus $4.8M a year earlier. Nine-month revenues rose 108.1% to $658.9M, driven by produced water handling growth, while Q3 net income attributable to WaterBridge Infrastructure LLC was $5.5M. However, water solutions revenue declined (Q3 $7.9M vs $9.8M, down 20.1%) and gain/loss figures and interest expense rose sharply, weighing on profitability.

  • · Water solutions revenue declined 20.1% YoY in Q3 2026 (from $9.8M to $7.9M), and related-party water solutions revenue grew only modestly
  • · Q3 2026 gain on disposal of assets was $31K versus a $141K loss in Q3 2025; nine-month 2025 included an $11.8M loss on disposals
  • · Accrued interest rose to $46.2M at September 30, 2026 from $22.0M at December 31, 2025, signaling higher debt-service pressure
  • · Cash and equivalents fell to $34.7M from $51.5M at year-end 2025 despite $540M of new debt proceeds, as capex and acquisitions consumed cash
  • · Tax receivable agreement liability increased to $296.0M from $201.4M at year-end 2025
  • · Class A shares outstanding rose to 55.8M from 43.3M, reflecting Class B redemptions and RSU vesting
  • · Q3 2026 net income attributable to noncontrolling interest was $7.8M, versus a $2.2M loss in Q3 2025

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US Earnings Financial Results SEC Filings

🇺🇸 More from United States

View all →